PRDX1

peroxiredoxin 1, the group of Peroxiredoxins

Basic information

Region (hg38): 1:45510914-45542732

Previous symbols: [ "PAGA" ]

Links

ENSG00000117450NCBI:5052OMIM:176763HGNC:9352Uniprot:Q06830AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • methylmalonic aciduria and homocystinuria type cblC (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Methylmalonic aciduria and homocystinuria, cblC type, digenicAR/DigenicBiochemicalWhile no treatment is completely effective, specific dietary (eg, high-calorie, low protein diet and avoidance of fasting, with measures taken to avoid/treat decompensation) and other medical measures (eg, cofactor therapy) may be beneficial to treat and prevent sequelae in the acute and chronic statesBiochemical; Cardiovascular; Dermatologic; Hematologic; Neurologic; Ophthalmologic; Renal29302025
Compound heterozygosity and digenic inheritance (with MMACHC) has been described

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PRDX1 gene.

  • METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC (1 variants)
  • Cobalamin C disease (1 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PRDX1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
10
clinvar
11
missense
16
clinvar
16
nonsense
1
clinvar
1
start loss
0
frameshift
2
clinvar
2
inframe indel
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
splice region
1
1
2
non coding
2
clinvar
3
clinvar
10
clinvar
15
Total 1 0 22 13 10

Variants in PRDX1

This is a list of pathogenic ClinVar variants found in the PRDX1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-45510915-A-G Disorders of Intracellular Cobalamin Metabolism Benign (Jan 13, 2018)297529
1-45510916-T-A Disorders of Intracellular Cobalamin Metabolism Uncertain significance (Jan 13, 2018)297530
1-45510929-A-G Disorders of Intracellular Cobalamin Metabolism Uncertain significance (Jan 13, 2018)297531
1-45510958-C-T Disorders of Intracellular Cobalamin Metabolism Uncertain significance (Jan 13, 2018)876535
1-45511371-A-G Likely benign (Sep 15, 2021)1665330
1-45511375-T-G Uncertain significance (Jan 26, 2022)1927058
1-45511377-GA-G Uncertain significance (Dec 09, 2023)2701912
1-45511406-C-A Uncertain significance (Nov 20, 2023)1902458
1-45511415-C-A METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC • Cobalamin C disease Pathogenic (Apr 11, 2023)495209
1-45511416-T-A METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE, DIGENIC Pathogenic (Apr 04, 2023)495210
1-45511583-CAT-C Benign (May 22, 2021)1251776
1-45514499-T-C Likely benign (Jan 02, 2024)2082807
1-45514518-T-C Inborn genetic diseases Uncertain significance (May 04, 2023)2543764
1-45514564-C-G Uncertain significance (Apr 21, 2022)1351486
1-45514580-G-A Likely benign (Sep 10, 2023)2759973
1-45514647-G-T Likely benign (Dec 21, 2023)2741053
1-45514651-TGAAAG-T Likely benign (Aug 14, 2023)2748538
1-45514864-A-T Likely benign (Dec 28, 2023)754054
1-45514913-C-G Inborn genetic diseases Uncertain significance (Jan 18, 2022)2285128
1-45514916-G-A Uncertain significance (Jul 14, 2022)2072613
1-45514924-G-C Inborn genetic diseases Uncertain significance (Feb 05, 2024)3218484
1-45514954-T-C Inborn genetic diseases Uncertain significance (Nov 08, 2022)2083086
1-45514958-T-C Uncertain significance (May 03, 2022)2415290
1-45514959-G-A Likely benign (Aug 22, 2022)2078536
1-45514967-G-A PRDX1-related disorder Benign (Nov 19, 2023)1552209

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PRDX1protein_codingprotein_codingENST00000262746 512012
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
7.70e-100.02181256870601257470.000239
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.2001031090.9460.000005361320
Missense in Polyphen3541.1960.8496513
Synonymous-0.1294039.01.030.00000193373
Loss of Function-1.08128.591.403.63e-7107

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005490.000547
Ashkenazi Jewish0.0007020.000695
East Asian0.0002790.000272
Finnish0.000.00
European (Non-Finnish)0.0002970.000290
Middle Eastern0.0002790.000272
South Asian0.00006530.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Thiol-specific peroxidase that catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and alcohols, respectively. Plays a role in cell protection against oxidative stress by detoxifying peroxides and as sensor of hydrogen peroxide-mediated signaling events. Might participate in the signaling cascades of growth factors and tumor necrosis factor-alpha by regulating the intracellular concentrations of H(2)O(2) (PubMed:9497357). Reduces an intramolecular disulfide bond in GDPD5 that gates the ability to GDPD5 to drive postmitotic motor neuron differentiation (By similarity). {ECO:0000250|UniProtKB:P0CB50, ECO:0000269|PubMed:9497357}.;
Pathway
Peroxisome - Homo sapiens (human);Androgen receptor signaling pathway;Selenium Micronutrient Network;Nuclear Receptors Meta-Pathway;NRF2 pathway;Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer,s disease models;Neurodegenerative Diseases;Disease;Detoxification of Reactive Oxygen Species;Gene expression (Transcription);Generic Transcription Pathway;Cellular responses to stress;RNA Polymerase II Transcription;AndrogenReceptor;TP53 Regulates Metabolic Genes;Cellular responses to external stimuli;Coregulation of Androgen receptor activity;Transcriptional Regulation by TP53 (Consensus)

Recessive Scores

pRec
0.732

Intolerance Scores

loftool
0.944
rvis_EVS
-0.25
rvis_percentile_EVS
35.42

Haploinsufficiency Scores

pHI
0.843
hipred
Y
hipred_score
0.734
ghis
0.620

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.998

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Prdx1
Phenotype
hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); neoplasm; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype;

Gene ontology

Biological process
skeletal system development;retina homeostasis;response to oxidative stress;cell population proliferation;removal of superoxide radicals;natural killer cell activation;regulation of stress-activated MAPK cascade;erythrocyte homeostasis;cellular response to oxidative stress;natural killer cell mediated cytotoxicity;hydrogen peroxide catabolic process;leukocyte activation;cell redox homeostasis;oxidation-reduction process;regulation of NIK/NF-kappaB signaling
Cellular component
extracellular space;nucleus;cytoplasm;cytosol;melanosome;myelin sheath;extracellular exosome
Molecular function
RNA binding;peroxidase activity;protein binding;thioredoxin peroxidase activity;identical protein binding;cadherin binding